SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001013596-11-000008
Filing Date
2011-03-30
Accepted
2011-03-30 17:02:27
Documents
8
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR ENDED DECEMBER 31, 2010 fm10k_12-10.htm 10-K 767292
2 sun-img1.jpg GRAPHIC 15856
3 sun-img2.jpg GRAPHIC 22731
4 sun-img3.jpg GRAPHIC 11304
5 LIST OF SUBSIDIARIES exh21-2.htm EX-21.2 1404
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER exh31-1.htm EX-31.1 14906
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER exh31-2.htm EX-31.2 14903
8 CERTIFICATION OF CHIEF EXECUTIVE & CHIEF FINANCIAL OFFICER exh32-1.htm EX-32.1 6439
  Complete submission text file 0001013596-11-000008.txt   875259
Mailing Address 6100 ROYALMOUNT AVENUE MONTREAL A8 H4P 2R2
Business Address 6100 ROYALMOUNT AVENUE MONTREAL A8 H4P 2R2 514-496-5197
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52898 | Film No.: 11722795
SIC: 8742 Services-Management Consulting Services